Tamoxifen: Five versus ten years - Is the end in sight?

被引:11
作者
Abrams, JA [1 ]
机构
[1] NCI, Canc Therapy Evaluat Program, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1093/jnci/93.9.662
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:662 / 664
页数:3
相关论文
共 22 条
[1]  
ABE O, 1992, LANCET, V339, P71
[2]  
[Anonymous], 1985, JAMA, V254, P3461
[3]  
[Anonymous], BREAST CANC RES TREA
[4]  
Carlson R W, 1997, Semin Oncol, V24, pS1
[5]  
Clarke M, 1998, LANCET, V351, P1451
[6]   Tamoxifen adjuvant treatment duration in early breast cancer:: Initial results of a randomized study comparing short-term treatment with long-term treatment [J].
Delozier, T ;
Spielmann, M ;
Macé-Lesec'h, J ;
Janvier, M ;
Hill, C ;
Asselain, B ;
Julien, JP ;
Weber, B ;
Mauriac, L ;
Petit, JC ;
Kerbrat, P ;
Malhaire, JP ;
Vennin, P ;
Leduc, B ;
Namer, M .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (20) :3507-3512
[7]   Early stopping of a clinical trial when there is evidence of no treatment benefit: Protocol B-14 of the National Surgical Adjuvant Breast and Bowel Project [J].
Dignam, JJ ;
Bryant, J ;
Wieand, HS ;
Fisher, B ;
Wolmark, N .
CONTROLLED CLINICAL TRIALS, 1998, 19 (06) :575-588
[8]  
Earl H, 1997, Clin Oncol (R Coll Radiol), V9, P141, DOI 10.1016/S0936-6555(97)80067-2
[9]   Five versus more than five years of tamoxifen for lymph node-negative breast cancer: Updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial [J].
Fisher, B ;
Dignam, J ;
Bryant, J ;
Wolmark, N .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (09) :684-690
[10]   Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors [J].
Fisher, B ;
Dignam, J ;
Bryant, J ;
DeCillis, A ;
Wickerham, DL ;
Wolmark, N ;
Costantino, J ;
Redmond, C ;
Fisher, ER ;
Bowman, DM ;
Deschenes, L ;
Dimitrov, NV ;
Margolese, RG ;
Robidoux, A ;
Shibata, H ;
Terz, J ;
Paterson, AHG ;
Feldman, MI ;
Farrar, W ;
Evans, J ;
Lickley, HL .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (21) :1529-1542